TREVISANI, Francesco
TREVISANI, Francesco
Mostra
prodotti
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.003 secondi).
Overview of immune checkpoint inhibitors therapy for hepatocellular carcinoma, and the ITA.LI.ca cohort derived estimate of amenability rate to immune checkpoint inhibitors in clinical practice
2019 Giannini, E. G.; Aglitti, A.; Borzio, M.; Gambato, M.; Guarino, M.; Iavarone, M.; Lai, Q.; Sandri, G. B. L.; Melandro, F.; Morisco, F.; Ponziani, F. R.; Rendina, M.; Russo, F. P.; Sacco, R.; Vigano, M.; Vitale, A.; Trevisani, F.
Renal function outcomes in metastatic non-small-cell lung carcinoma patients treated with chemotherapy or immune checkpoint inhibitors: an unexpected scenario
2022 Trevisani, F; Di Marco, F; Floris, M; Pani, A; Minnei, R; Scartozzi, M; Cirillo, A; Gelibter, A; Botticelli, A; Rijavec, E; Cattaneo, M; Garrone, O; Ghidini, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Overview of immune checkpoint inhibitors therapy for hepatocellular carcinoma, and the ITA.LI.ca cohort derived estimate of amenability rate to immune checkpoint inhibitors in clinical practice | 2019 | Giannini, E. G.; Aglitti, A.; Borzio, M.; Gambato, M.; Guarino, M.; Iavarone, M.; Lai, Q.; Sandri, G. B. L.; Melandro, F.; Morisco, F.; Ponziani, F. R.; Rendina, M.; Russo, F. P.; Sacco, R.; Vigano, M.; Vitale, A.; Trevisani, F. | |
| Renal function outcomes in metastatic non-small-cell lung carcinoma patients treated with chemotherapy or immune checkpoint inhibitors: an unexpected scenario | 2022 | Trevisani, F; Di Marco, F; Floris, M; Pani, A; Minnei, R; Scartozzi, M; Cirillo, A; Gelibter, A; Botticelli, A; Rijavec, E; Cattaneo, M; Garrone, O; Ghidini, M. |